Adial Pharmaceuticals (ADIL) Earnings Date, Estimates & Call Transcripts $1.00 -0.01 (-0.50%) (As of 03:39 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Adial Pharmaceuticals Latest Earnings SummaryLatest Earnings DateAug. 13EstimatedActual EPS (Aug. 13) -$0.59 Missed By -$0.20 Consensus EPS (Aug. 13) -$0.39 Adial Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.59, which missed the consensus estimate of -$0.39 by $0.20. With a trailing EPS of $0.00, Adial Pharmaceuticals' earnings are expected to grow next year, from ($1.79) to ($1.51) per share. Get Adial Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adial Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataADIL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADIL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 Media“Sleeping Giant” Crypto Set to Explode…What if I told you there's a crypto that could make Bitcoin look like small change? We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late Adial Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.58-$0.51-$0.55Q2 20242-$0.58-$0.39-$0.49Q3 20242-$0.52-$0.50-$0.51Q4 20242-$0.52-$0.39-$0.46FY 20248-$2.20-$1.79-$2.00Q1 20251-$0.39-$0.39-$0.39Q2 20251-$0.39-$0.39-$0.39Q3 20251-$0.39-$0.39-$0.39Q4 20251-$0.39-$0.39-$0.39FY 20254($1.56)($1.56)($1.56) Adial Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/13/2024--$0.39-$0.59 -$0.20-$0.59--5/14/2024Q1 2024-$0.51-$0.68 -$0.17$0.83--11/14/2023Q3 2023-$1.14-$1.14--$1.10--8/21/2023Q2 2023-$1.50-$1.33+$0.17-$3.62--5/12/2023Q1 2023-$3.50-$2.75+$0.75-$0.11--3/30/2023Q4 2022-$3.75-$2.75+$1.00-$0.11-- Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Adial Pharmaceuticals Earnings - Frequently Asked Questions When did Adial Pharmaceuticals announce their last quarterly earnings? Adial Pharmaceuticals (NASDAQ:ADIL) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on ADIL's earnings history. Did Adial Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Adial Pharmaceuticals (NASDAQ:ADIL) missed the analysts' consensus estimate of ($0.39) by $0.20 with a reported earnings per share (EPS) of ($0.59). Learn more on analysts' earnings estimate vs. ADIL's actual earnings. How much profit does Adial Pharmaceuticals generate each year? Adial Pharmaceuticals (NASDAQ:ADIL) has a recorded net income of -$5.12 million. ADIL has generated $0.00 earnings per share over the last four quarters. What is Adial Pharmaceuticals's EPS forecast for next year? Adial Pharmaceuticals's earnings are expected to grow from ($1.79) per share to ($1.51) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies EQ Earnings CLDI Earnings LPCN Earnings ATHA Earnings BTAI Earnings GOVX Earnings LSTA Earnings CMMB Earnings CVKD Earnings ACXP Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report “Sleeping Giant” Crypto Set to Explode… (Ad)What if I told you there's a crypto that could make Bitcoin look like small change? We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late This page (NASDAQ:ADIL) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk In Trump’s “Inner Circle”Elon Musk is one of Donald Trump’s closest allies. Since the election, he’s spent several days at Mar-a-Lag...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
